Farabi Pharmaceutical (XTEH:DFRB1) NonCurrent Deferred Liabilities: IRR0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Farabi Pharmaceutical NonCurrent Deferred Liabilities?

Farabi Pharmaceutical XTEH:DFRB1 NonCurrent Deferred Liabilities is IRR0.00 Mil as of . 20.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Farabi Pharmaceutical's non-current deferred liabilities for the quarter that ended in . 20 was IRR0.00 Mil.

Farabi Pharmaceutical NonCurrent Deferred Liabilities Related Terms

Farabi Pharmaceutical NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical NonCurrent Deferred Liabilities Chart

Farabi Pharmaceutical Annual Data
Trend
NonCurrent Deferred Liabilities

Farabi Pharmaceutical Quarterly Data
NonCurrent Deferred Liabilities
What does a NonCurrent Deferred Liabilities of IRR0.00 Mil mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a NonCurrent Deferred Liabilities of IRR0.00 Mil as of . 20. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's NonCurrent Deferred Liabilities too high?
Farabi Pharmaceutical's current NonCurrent Deferred Liabilities is IRR0.00 Mil.
How does Farabi Pharmaceutical's NonCurrent Deferred Liabilities compare to IMNPQ and INNV?
Farabi Pharmaceutical's NonCurrent Deferred Liabilities of IRR0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Drug Manufacturers company?
A good NonCurrent Deferred Liabilities depends on the Drug Manufacturers industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Farabi Pharmaceutical and its competitors. Farabi Pharmaceutical's current NonCurrent Deferred Liabilities is IRR0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current NonCurrent Deferred Liabilities of IRR0.00 Mil. The current NonCurrent Deferred Liabilities is IRR0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current NonCurrent Deferred Liabilities is IRR0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.